EA202092542A2 - NEW PEPTIDES AND COMBINATIONS OF PEPTIDES AND FRAMEWORK FOR USE IN IMMUNOTHERAPY OF RENAL CELL CARCINOMA (RCC) AND OTHER TYPES OF CANCER - Google Patents

NEW PEPTIDES AND COMBINATIONS OF PEPTIDES AND FRAMEWORK FOR USE IN IMMUNOTHERAPY OF RENAL CELL CARCINOMA (RCC) AND OTHER TYPES OF CANCER

Info

Publication number
EA202092542A2
EA202092542A2 EA202092542A EA202092542A EA202092542A2 EA 202092542 A2 EA202092542 A2 EA 202092542A2 EA 202092542 A EA202092542 A EA 202092542A EA 202092542 A EA202092542 A EA 202092542A EA 202092542 A2 EA202092542 A2 EA 202092542A2
Authority
EA
Eurasian Patent Office
Prior art keywords
peptides
cells
immunotherapy
cancer
rcc
Prior art date
Application number
EA202092542A
Other languages
Russian (ru)
Other versions
EA202092542A3 (en
Inventor
Андреа Мар
Тони Вайншенк
Оливер Шоор
Дженс Фрицше
Харприт Сингх
Колетт Сонг
Original Assignee
Имматикс Байотекнолоджиз Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Имматикс Байотекнолоджиз Гмбх filed Critical Имматикс Байотекнолоджиз Гмбх
Publication of EA202092542A2 publication Critical patent/EA202092542A2/en
Publication of EA202092542A3 publication Critical patent/EA202092542A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Настоящее изобретение относится к пептидам, белкам, нуклеиновым кислотам и клеткам для применения в иммунотерапевтических методах. В частности, настоящее изобретение относится к иммунотерапии рака. Настоящее изобретение относится далее к опухолеассоциированным пептидным эпитопам T-клеток, в отдельности или в комбинации с другими опухолеассоциированными пептидами, которые могут, например, служить в качестве активных фармацевтических ингредиентов вакцинных композиций, стимулирующих противоопухолевые иммунные ответы, или стимулировать T-клетки ex vivo с их перенесением в организм пациента. Пептиды, связанные с молекулами главного комплекса гистосовместимости (MHC), или пептиды в отдельности могут быть также мишенями антител, растворимых T-клеточных рецепторов и других связывающих молекул.The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to cancer immunotherapy. The present invention further relates to tumor-associated peptide epitopes of T cells, alone or in combination with other tumor-associated peptides, which can, for example, serve as active pharmaceutical ingredients in vaccine compositions that stimulate anti-tumor immune responses, or stimulate T cells ex vivo with their transfer to the patient's body. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides alone, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.

EA202092542A 2015-03-31 2016-03-24 NEW PEPTIDES AND COMBINATIONS OF PEPTIDES AND FRAMEWORK FOR USE IN IMMUNOTHERAPY OF RENAL CELL CARCINOMA (RCC) AND OTHER TYPES OF CANCER EA202092542A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562140767P 2015-03-31 2015-03-31

Publications (2)

Publication Number Publication Date
EA202092542A2 true EA202092542A2 (en) 2021-02-26
EA202092542A3 EA202092542A3 (en) 2021-06-30

Family

ID=74855457

Family Applications (4)

Application Number Title Priority Date Filing Date
EA202092543A EA202092543A3 (en) 2015-03-31 2016-03-24 NEW PEPTIDES AND COMBINATIONS OF PEPTIDES AND FRAMEWORK FOR USE IN IMMUNOTHERAPY OF RENAL CELL CARCINOMA (RCC) AND OTHER TYPES OF CANCER
EA202092560A EA202092560A3 (en) 2015-03-31 2016-03-24 NEW PEPTIDES AND COMBINATIONS OF PEPTIDES AND FRAMEWORK FOR USE IN IMMUNOTHERAPY OF RENAL CELL CARCINOMA (RCC) AND OTHER TYPES OF CANCER
EA202092542A EA202092542A3 (en) 2015-03-31 2016-03-24 NEW PEPTIDES AND COMBINATIONS OF PEPTIDES AND FRAMEWORK FOR USE IN IMMUNOTHERAPY OF RENAL CELL CARCINOMA (RCC) AND OTHER TYPES OF CANCER
EA202092559A EA202092559A3 (en) 2015-03-31 2016-03-24 NEW PEPTIDES AND COMBINATIONS OF PEPTIDES AND FRAMEWORK FOR USE IN IMMUNOTHERAPY OF RENAL CELL CARCINOMA (RCC) AND OTHER TYPES OF CANCER

Family Applications Before (2)

Application Number Title Priority Date Filing Date
EA202092543A EA202092543A3 (en) 2015-03-31 2016-03-24 NEW PEPTIDES AND COMBINATIONS OF PEPTIDES AND FRAMEWORK FOR USE IN IMMUNOTHERAPY OF RENAL CELL CARCINOMA (RCC) AND OTHER TYPES OF CANCER
EA202092560A EA202092560A3 (en) 2015-03-31 2016-03-24 NEW PEPTIDES AND COMBINATIONS OF PEPTIDES AND FRAMEWORK FOR USE IN IMMUNOTHERAPY OF RENAL CELL CARCINOMA (RCC) AND OTHER TYPES OF CANCER

Family Applications After (1)

Application Number Title Priority Date Filing Date
EA202092559A EA202092559A3 (en) 2015-03-31 2016-03-24 NEW PEPTIDES AND COMBINATIONS OF PEPTIDES AND FRAMEWORK FOR USE IN IMMUNOTHERAPY OF RENAL CELL CARCINOMA (RCC) AND OTHER TYPES OF CANCER

Country Status (1)

Country Link
EA (4) EA202092543A3 (en)

Also Published As

Publication number Publication date
EA202092543A2 (en) 2021-02-26
EA202092559A3 (en) 2021-09-30
EA202092543A3 (en) 2021-06-30
EA202092560A3 (en) 2021-09-30
EA202092560A2 (en) 2021-06-30
EA202092542A3 (en) 2021-06-30
EA202092559A2 (en) 2021-06-30

Similar Documents

Publication Publication Date Title
EA201992664A3 (en) NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF OVARIAN CANCER AND OTHER TYPES OF CANCER
MX2022000219A (en) Novel peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (rcc) and other cancers.
EA202191027A2 (en) NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF SEVERAL TUMORS
EA201891465A1 (en) PEPTIDES AND COMBINATIONS OF PEPTIDES FOR APPLICATION IN BREAST CANCER IMMUNOTHERAPY AND OTHER CANCER TYPES
EA201891116A1 (en) NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR THE USE OF SEVERAL CANCER TYPES IN IMMUNOTHERAPY
EA201792484A1 (en) NEW CELL EPITOPES AND COMBINATION OF CELL EPITOPES FOR USE OF MYELOMA AND OTHER CANCER IN IMMUNOTHERAPY
EA201792242A1 (en) NEW PEPTIDES AND COMBINATIONS OF PEPTIDES AND THEIR CARDS FOR USE IN COLORECTAL CARCINOMA AND OTHER CANCER IN IMMUNOTHERAPY
EA202092560A3 (en) NEW PEPTIDES AND COMBINATIONS OF PEPTIDES AND FRAMEWORK FOR USE IN IMMUNOTHERAPY OF RENAL CELL CARCINOMA (RCC) AND OTHER TYPES OF CANCER
EA202191120A3 (en) PEPTIDES AND THEIR COMBINATIONS FOR USE IN CANCER IMMUNOTHERAPY
EA202190357A2 (en) NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF SEVERAL TYPES OF CANCER
EA202190465A3 (en) NEW PEPTIDES AND PEPTIDE COMBINATIONS FOR USE IN NHL IMMUNOTHERAPY AND OTHER CANCER
EA202190241A1 (en) NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF CLL AND OTHER TYPES OF CANCER
EA202190896A2 (en) NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF PANCREAS CANCER AND OTHER TYPES OF CANCER
EA202191013A3 (en) NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY AND METHODS FOR OBTAINING FRAMEWORK FOR USE IN TREATMENT OF PANCREAS CANCER AND OTHER TYPES OF CANCER
EA202091879A2 (en) NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF LUNG CANCER, INCLUDING NON-SMALL CELL LUNG CANCER (NSCLC) AND OTHER TYPES OF CANCER